EMA has published a Guideline on specific adverse reaction follow-up questionnaries (Specific AR FUQ)

T1,T2,T3

More information

PrevPreviousEMA has published an update of the ‘Product Management Service’ roadmap

NextEMA has published a new update (v 1.7.2443-15) of the ‘Union Product Database (UPD) release notes’Next

Pamplona

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Additional Cookies

This website uses the following additional cookies:

(List the cookies that you are using on the website here.)

Enable or Disable Cookies

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy

EMA has published a Guideline on specific adverse reaction follow-up questionnaries (Specific AR FUQ)

Zaragoza

Pamplona